Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
McKesson
Merck
Express Scripts
Colorcon

Last Updated: January 21, 2020

DrugPatentWatch Database Preview

Heritage Pharms Inc Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for HERITAGE PHARMS INC, and what generic and branded alternatives to HERITAGE PHARMS INC drugs are available?

HERITAGE PHARMS INC has forty approved drugs.



Summary for Heritage Pharms Inc
US Patents:0
Tradenames:37
Ingredients:36
NDAs:40

Drugs and US Patents for Heritage Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Heritage Pharms Inc OCTREOTIDE ACETATE octreotide acetate INJECTABLE;INJECTION 204669-002 Dec 27, 2018 AP RX No No   Start Trial   Start Trial
Heritage Pharms Inc VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET;ORAL 078554-002 Jan 9, 2009 AB RX No No   Start Trial   Start Trial
Heritage Pharms Inc SULFASALAZINE sulfasalazine TABLET;ORAL 080197-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Heritage Pharms Inc ALPRAZOLAM alprazolam TABLET, EXTENDED RELEASE;ORAL 078489-002 Oct 17, 2008 AB RX No No   Start Trial   Start Trial
Heritage Pharms Inc KETOPROFEN ketoprofen CAPSULE;ORAL 074014-001 Jan 29, 1993 RX No No   Start Trial   Start Trial
Heritage Pharms Inc OCTREOTIDE ACETATE octreotide acetate INJECTABLE;INJECTION 203765-002 Sep 7, 2018 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Heritage Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Heritage Pharms Inc LIMBITROL amitriptyline hydrochloride; chlordiazepoxide TABLET;ORAL 016949-001 Approved Prior to Jan 1, 1982 4,316,897   Start Trial
Heritage Pharms Inc LIMBITROL DS amitriptyline hydrochloride; chlordiazepoxide TABLET;ORAL 016949-002 Approved Prior to Jan 1, 1982 4,316,897   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Baxter
AstraZeneca
Medtronic
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.